Learning Center

Learning Center

Catalog Advanced Search

Search by Category
Search by Format
Sort By
Search by Type
Search by Category
Search in Packages
Search by Format
Search by Type
Search by Date Range
Products are filtered by different dates, depending on the combination of live and on-demand components that they contain, and on whether any live components are over or not.
Start
End
Search by Keyword
Sort By
  • Includes Multiple Live Events. The next is on 12/07/2024 at 10:00 AM (EST)

    Course Date: December 7 & 8, 2024. The core elements of this program focus on performing quality DXA scans, dissecting the data and applying this knowledge to a technologist’s role in patient care. This course, which focuses on quality DXA, is innovative, interactive and informative. The course emphasizes technical excellence in the performance, analysis and troubleshooting of bone densitometry scans. It provides standard practices and applications to raise the quality of DXA scan procedures and their impact on patient care. The program is designed to enhance awareness of the technical expertise involved in performing bone densitometry and applying protocols to address the everyday challenges. Attendees with come away with a strong sense of the considerable impact that a technologist plays in the delivery of quality DXA, and how that influences patient management.

    Course Date

    December 7 & 8, 2024.


    Course Description

    The core elements of this program focus on performing quality DXA scans, dissecting the data and applying this knowledge to a technologist’s role in patient care. This course, which focuses on quality DXA, is innovative, interactive and informative.  The course emphasizes technical excellence in the performance, analysis and troubleshooting of bone densitometry scans. It provides standard practices and applications to raise the quality of DXA scan procedures and their impact on patient care. The program is designed to enhance awareness of the technical expertise involved in performing bone densitometry and applying protocols to address the everyday challenges. Attendees with come away with a strong sense of the considerable impact that a technologist plays in the delivery of quality DXA, and how that influences patient management.


    Target Audience

    The course is most appropriate for those involved in the performance of DXA scans and open to any health professional performing these scans.


    Learning Objectives

    After attending the course, participants should be better prepared to:

    1. Design and implement quality control and assurance practices.
    2. Perform a precision assessment and appreciate the requirement for clinical care.  
    3. Identify the anatomy relevant to clinical DXA scanning. 
    4. Implement consistent and appropriate technical acquisition and analysis techniques.  
    5. Perform a fracture risk assessment using FRAX. 
    6. Provide DXA interpreters sufficient information for a high-quality DXA report. 
    7. Discuss supplemental software and their application.
    8. Demonstrate how to access features within the DXA software. 
    9. Understand how specific medical conditions and medications affect bone density. 
    10. Critically evaluate DXA scans to identify acquisition and analysis errors and implement resolution methods.
    11. Recognize how technical errors impact clinical interpretation and patient care.



      Method of Participation

      This activity will be offered through zoom, allowing the learner to watch and ask questions in a live format on December 7 & 8, 2024. Learners will be asked to complete a post-course survey to indicate what they will change in their practice as a result of this activity.

      Registration Fee

      image



      Cancellation Policy

      Attendee Cancellation Policy All changes in registration must be made in writing to education@iscd.org. Cancellations received 30 days prior to the start of the program are eligible for a full refund minus a $50 administrative fee. Cancellations received less than 30 days prior to the start of the course will not be refunded.

      Course Changes or Cancellations ISCD reserves the right to cancel the program, change dates and/or meeting location. If a program is canceled, all program fees will be refunded automatically unless the registered participant elects to transfer to another program. Participants will be notified of any changes within 21 days of the course start date.

      ASRT Credit Designation 

      This activity has been approved by ASRT for 13.0 Category A continuing education credits.

      ASRT Credit Notice

      This course is a renewal. If you have taken the course since June 2022, you will not be able to claim ASRT again for this learning activity. If you have taken prior to June 2022, you can take this course again for credit.

      Deadline to Claim Credit

      Participants will have 90 days from the activity end date to complete the activity survey and claim continuing education credit.

      Schedule - Day 1 - All times Eastern (NYC/USA)

      image

      Schedule - Day 2 - All times Eastern (NYC/USA)

      image

      Anita Colquhoun, RTNM, MRT(N), CDT

      Charge Technologist

      Women's College Hospital

      Anita Colquhoun M.R.T.(N), CDT is the charge technologist in the Centre for Osteoporosis & Bone Health at the Women’s College Hospital in Toronto. Anita is a Nuclear Medical Technologist specialized in Bone Mineral Density (BMD). She has been working in the field of BMD since the early 1990s. Anita is an active member ISCD Technologist Faculty since 2000. She has served 2 terms on the Governing Board of the ISCD and is currently serving her third term as the Executive Secretary to the Board. As well as Chairing then Annual Meeting Committee from 2012-2016 Anita served and is still serving on several other committees within the ISCD. She has participated in a variety of research studies and has co-authored abstracts and papers. Anita has also co-written an on-line beginner BMD course as well as developed a competency profile and best practise in BMD for the Ontario Association of Medical Radiation Sciences.

      Diane Krueger, BS, CBDT

      Researcher

      Osteoporosis Clinical Research Program - University of Wisconsin, Madison

      Diane Krueger received her Bachelor of Science degree at the University of Wisconsin-Madison. She is an ISCD-certified clinical densitometrist and a certified clinical research coordinator through the Association of Clinical Research Professionals. She has been program manager of the University of Wisconsin Osteoporosis Clinical Research Program since its inception in 1993. Ms. Krueger has extensive clinical research experience in osteoporosis and bone densitometry, having coordinated multiple industry and investigator-initiated studies. In collaboration with the UW Osteoporosis Program, she has published over 90 manuscripts and authored or presented over 200 abstracts. Her service with ISCD has included serving as Technologist Bone Densitometry Course faculty since 2006 and chairing the related Update Annual Meeting Committees. In her leadership capacity, she is currently Education Council chair and serves on the Executive Committee and Board. Additionally, she previously held several officer positions including Secretary and four Presidential seats.

      Greg Yardley

      Sr. Medical Radiology Technologist and Researcher

      NASA Bone Mineral Laboratory

      Greg Yardley works as a SR. Medical Radiology Technologist and researcher in the NASA Bone Mineral Laboratory and NASA/JSC medical clinic for KBR in the government solutions division. His job requirements are performing and analyzing, Dual Energy x-ray absorptiometry (DXA) exams on both retired and active Astronauts. He also extracts, records, aids in bone density interpretation and distributes bone data from Dual Energy xray absorptiometry (DXA), Computed Tomography (CT), Magnetic resonance imaging devises. Greg also performs diagnostic medical x-rays for the NASA/JSC Flight medicine and occupational health clinic. 

      Greg began his healthcare career as an Emergency Medical Technician (EMT). He then furthered his medical education and received his certification as a registered radiology technologist. Upon completion of his Radiological Science courses. Greg has worked as a Radiology technologist in a Trauma level 1 Hospital, Level III hospital, urgent care, and multi-specialty clinic. At the time of his graduation Greg had also received extensive training not only in X-ray but also DXA, CT, and Ultrasound. In 2011 just previous to his current job Greg got a job as a Bone Density Technologist at a multi-specialty medical clinic where he performed and analyzed over 3000 DXA scans a year on every type of patient imaginable while also running the day-to-day operations of the Osteoporosis center.

      image

      Statement of Independence

      The ISCD maintains a policy on the use of commercial support, which ensures that all educational activities sponsored by the ISCD provide in-depth presentations that are fair, balanced, independent, and scientifically rigorous. ISCD requires faculty, planners, managers, and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by ISCD for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. Individual disclosures are included in the course material. No Commercial Support has been provided for this activity

      Disclaimer

      The information and suggestions presented at the courses, seminars and other programs sponsored by ISCD and other collaborating societies are subject to change and therefore should serve only as a foundation for further investigation and study. Any forms presented at our seminars or programs are samples only and are not necessarily authoritative. All information, procedures, and forms contained or used in such seminars or programs should serve only as a guide for use in specific situations.

      Disclosure of Unlabeled Use

      This educational activity may contain a discussion of published and/or investigational uses of agents that are not indicated by the FDA. ISCD does not recommend the use of any agent outside of the labeled indications. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for a discussion of approved indications, contraindications, and warnings.

      Privacy & Confidentiality Statement

      The ISCD will record the learner’s personal information as provided on evaluations to allow for the issuance and tracking of CME/CE certificates. The ISCD may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its educational program. No individual performance data or any other personal information collected for evaluations will be shared with third parties

      Attendance Cancellation Policy

      All changes in registration must be made in writing to education@iscd.org. Cancellations received 30 days prior to the start of the program are eligible for a full refund minus a $50 administrative fee. Cancellations received less than 30 days prior to the start of the course will not be refunded.

      Course Changes or Cancellations

      ISCD reserves the right to cancel the program, change dates, how the course is taught, and/or meeting location. If a program is canceled, all program fees will be refunded unless the registered participant elects to transfer to another program. Participants will be notified of any changes within 21 days of the course start date.

    1. Includes Multiple Live Events. The next is on 12/07/2024 at 10:00 AM (EST)

      Course Date: December 7 & 8, 2024. The core elements of this course serve to educate healthcare providers about bone densitometry and osteoporosis and to apply standard practices to assure quality performance and interpretation of bone densitometry studies. The course is offered in two parts. The first day sets the standard to perform Quality DXA interpretation. Day 2 focuses on the clinical assessment, prevention, treatment and management of osteoporosis and the essential role that high-quality DXA plays in treatment initiation decisions and monitoring of osteoporotic patients. Individuals may register for either part of the course separately or as a combined program.

      Course Date

      December 7 & 8, 2024.


      Course Description

      The core elements of this course serve to educate healthcare providers about bone densitometry and osteoporosis and to apply standard practices to assure quality performance and interpretation of bone densitometry studies. The course is offered in two parts. The first day sets the standard to perform Quality DXA interpretation. Day 2 focuses on the clinical assessment, prevention, treatment and management of osteoporosis and the essential role that high-quality DXA plays in treatment initiation decisions and monitoring of osteoporotic patients. Individuals may register for either part of the course separately or as a combined program.


      Target Audience

      The course is most appropriate for those involved in the performance and interpretation of DXA scans and those managing patients with osteoporosis. It is open to MDs, PhDs, DOs, Nurse Practitioners, and Physician Assistants. Technologists may attend if they have previously taken the ISCD/IOF Osteoporosis Essentials for Technologists Course.


      Learning Objectives

      After attending the course, participants should be better prepared to:

      • Describe appropriate clinical evaluation of patients at risk for fragility fracture.
      • Summarize the value and importance of quality bone densitometry for the diagnosis of osteoporosis, assessment of fracture risk, and monitoring of BMD. 
      • Recognize errors in DXA analysis and reporting. 
      • Explain new and emerging guidelines that provide evidence-based information regarding skeletal health. 
      • Describe the use of current and new pharmacologic therapies for the management and treatment of osteoporosis, including adverse effects.

      Method of Participation

      This activity will be offered live streamed via Zoom, allowing the learner to watch and ask questions in a live format on December 7 & 8, 2024. Learners will be asked to complete a post-course survey to indicate what they will change in their practice as a result of this activity.

      Rates


      image


      Cancellation Policy

      Attendee Cancellation Policy All changes in registration must be made in writing to education@iscd.org. Cancellations received 30 days prior to the start of the program are eligible for a full refund minus a $50 administrative fee. Cancellations received less than 30 days prior to the start of the course will not be refunded.

      Course Changes or Cancellations ISCD reserves the right to cancel the program, change dates and/or meeting location. If a program is canceled, all program fees will be refunded automatically unless the registered participant elects to transfer to another program. Participants will be notified of any changes within 21 days of the course start date.

      ACCME Joint Accreditation Statement:

      In support of improving patient care, this activity has been planned and implemented by Amedco LLC and ISCD. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

      image

      AMA PRA Category 1 Credit(s)™

      Amedco LLC designates this live activity for a maximum of 13.00 AMA PRA Category 1 CreditsTM

      Physicians should claim only the credit commensurate with the extent of their participation in the activity.

      Deadline to Claim Credit:

      Participants will have 90 days from the activity end date to complete the activity survey and claim continuing education credit.

       Schedule - December 7th, 2024 - All times Eastern Standard Time (NYC/USA)

      image


       Schedule - December 8th, 2024 - All times Eastern Standard Time (NYC/USA)

      image


      Dr Neil Binkley MD, CCD

      Professor

      University of Wisconsin Madison

      Dr. Neil Binkley earned his medical degree from the University of Wisconsin and subsequently trained in Internal Medicine at the Marshfield Clinic. After several years in private practice, he returned to the University of Wisconsin and completed a Geriatrics fellowship. He is a Professor in the Divisions of Geriatrics and Endocrinology at the University of Wisconsin School of Medicine and Public Health. He is also Director of the UW Osteoporosis Clinical Research Program and Associate Director of the UW Institute on Aging. He is past President of the International Society for Clinical Densitometry, Associate Editor of Osteoporosis International and a member of the International Osteoporosis Foundation Committee of Scientific Advisors. His current research involves improvement in 25(OH)D measurement, evaluation of approaches to optimize assessment of vitamin D status, evaluation of functional assessment in older adults and the importance of sarcopenia in fracture risk. Dr. Binkley has published over 300 papers, served on expert committees and panels for AACE, ASBMR, IOF and ISCD.

      E. Michael Lewiecki, MD, FACP, FACE, CCD

      Director

      New Mexico Clinical Research & Osteoporosis Center, Inc.

      E. Michael Lewiecki, MD, CCD, FACP, FACE, FASBMR, is Director of New Mexico Clinical Research & Osteoporosis Center and Director of Bone Health TeleECHO at University of New Mexico Health Sciences Center in Albuquerque, NM. His is a consultant in osteoporosis and metabolic bone disease, supervisor and interpreter of bone density studies, and an educator with a special interest in the evaluation and treatment of osteoporosis and metabolic bone diseases. He has been principal investigator for many osteoporosis clinical trials and is author of over 300 publications in peer-reviewed medical journals, as well as books, book chapters, and online publications on osteoporosis. Dr. Lewiecki is past-president of the International Society for Clinical Densitometry (ISCD) and current president of the Osteoporosis Foundation of New Mexico (OFNM). He is an editor for Osteoporosis International, and is on the editorial boards of the Journal of Bone and Mineral Research and the Journal of Clinical Densitometry. He has received national and international awards that include the 2021 “Dr. John P. Bilezikian ISCD Global Leadership Award” and the 2021 “Lawrence G. Raisz Memorial Lecture Award” with the Bone Health & Osteoporosis Foundation. Dr. Lewiecki is the program director of the annual Santa Fe Bone Symposium, the flagship activity of the OFNM.

      Gillian Wooldridge, DO, CCD

      Gillian Wooldridge is a primary care sports medicine physician in Houston, Texas. She completed her undergraduate studies in Kinesiology-Sports Medicine at Rice University in 2009. She received her medical degree from the Texas College of Osteopathic Medicine in 2014, where she was the inaugural recipient of the Sports Medicine Achievement Award. Dr Wooldridge completed her family medicine residency in 2017 and sports medicine fellowship in 2018, with Houston Methodist and Houston Methodist Willowbrook Hospitals respectively. 

      She currently works for Houston Methodist Orthopedics and Sports Medicine in the Texas Medical Center. She serves as a team physician for Rice University Athletics and volunteers with several organizations in the community including the Chevron Houston Marathon, IronMan Texas and the Houston Livestock Show and Rodeo. Dr Wooldridge is a member of the board of directors for the American Osteopathic Academy of Sports Medicine and is actively involved in the American Medical Society of Sports Medicine as an item writer for the sports medicine in-training exam. 

      She is a certified clinical densitometrist and works on the Osteoporosis Essentials Course Committee and serves as a co-director of the Bone Health Initiative in the Houston Methodist Orthopedics and Sports Medicine department. She holds a core clinical faculty position with the Texas A&M College of Medicine Engineering & Medicine program and a clinical faculty position the Tillman Fertitta Family College of Medicine. 

      image

      Statement of Independence

      The ISCD maintains a policy on the use of commercial support, which ensures that all educational activities sponsored by the ISCD provide in-depth presentations that are fair, balanced, independent, and scientifically rigorous. ISCD requires faculty, planners, managers, and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by ISCD for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. Individual disclosures are included in the course material. No Commercial Support has been provided for this activity

      Disclaimer

      The information and suggestions presented at the courses, seminars and other programs sponsored by ISCD and other collaborating societies are subject to change and therefore should serve only as a foundation for further investigation and study. Any forms presented at our seminars or programs are samples only and are not necessarily authoritative. All information, procedures, and forms contained or used in such seminars or programs should serve only as a guide for use in specific situations.

      Disclosure of Unlabeled Use

      This educational activity may contain a discussion of published and/or investigational uses of agents that are not indicated by the FDA. ISCD does not recommend the use of any agent outside of the labeled indications. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for a discussion of approved indications, contraindications, and warnings.

      Privacy & Confidentiality Statement

      The ISCD will record the learner’s personal information as provided on evaluations to allow for the issuance and tracking of CME/CE certificates. The ISCD may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its educational program. No individual performance data or any other personal information collected for evaluations will be shared with third parties

      Attendance Cancellation Policy

      All changes in registration must be made in writing to education@iscd.org. Cancellations received 30 days prior to the start of the program are eligible for a full refund minus a $50 administrative fee. Cancellations received less than 30 days prior to the start of the course will not be refunded.

      Course Changes or Cancellations

      ISCD reserves the right to cancel the program, change dates, how the course is taught, and/or meeting location. If a program is canceled, all program fees will be refunded unless the registered participant elects to transfer to another program. Participants will be notified of any changes within 21 days of the course start date.

    2. Includes Multiple Live Events. The next is on 10/20/2024 at 10:00 AM (EDT)

      Course Date: October 20, 2024. This course focuses on increasing the knowledge and competence of clinicians and other healthcare professionals to help them successfully use DXA body composition analysis in the management of obesity, geriatric sarcopenia and other low muscle mass states, general health and pediatric skeletal disease. The inclusion of case studies will reinforce the knowledge gained and allow for application in the diagnosis, treatment and therapies of patients presenting with low bone mineral density.

      Course Date

      October 20, 2024, 10am-2pm ET

      Course Description

      This course focuses on increasing the knowledge and competence of clinicians and other healthcare professionals to help them successfully use DXA body composition analysis in the management of obesity, geriatric sarcopenia and other low muscle mass states, general health and pediatric skeletal disease. The inclusion of case studies will reinforce the knowledge gained and allow for application in the diagnosis, treatment and therapies of patients presenting with low bone mineral density.

      Target Audience

      The content is designed for healthcare providers responsible for reading and interpreting DXA scans, including specialists and generalists working in family medicine, general and internal medicine, rheumatology, endocrinology, obstetrics/gynecology, radiology, physical and occupational therapy, and research, as well as technologists.

      Learning Objectives

      After attending the course, participants should be better prepared to:

      1. Identify proper DXA technology for body composition analysis of fat, lean muscle and bone mass.
      2. List other methods of body composition analysis used in the clinical setting.
      3. Differentiate reference values and indices.
      4. Identify limitations of reference values and indices.
      5. Summarize scan acquisition for adult and pediatric patients.

      Method of Participation

      This activity will be offered through zoom, allowing the learner to watch and ask questions in a live format on October 20, 2024. At the end of the activity, learners will be asked to evaluate the activity online and then claim credit and print certificates. Participants will have 90 days from the activity end date to complete the activity survey and claim continuing education credit. 

      Rates

      image


      Cancellation Policy

      Attendee Cancellation Policy All changes in registration must be made in writing to education@iscd.org. Cancellations received 30 days prior to the start of the program are eligible for a full refund minus a $50 administrative fee. Cancellations received less than 30 days prior to the start of the course will not be refunded.

      Course Changes or Cancellations ISCD reserves the right to cancel the program, change dates and/or meeting location. If a program is canceled, all program fees will be refunded automatically unless the registered participant elects to transfer to another program. Participants will be notified of any changes within 21 days of the course start date.

      ACCME Joint Accreditation Statement

      image

      In support of improving patient care, this activity has been planned and implemented by Amedco LLC and ISCD. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

      AMA PRA Category 1 Credit(s)™

      This activity is currently under review for accreditation targeting 3.75 AMA PRA Category 1 Credit(s)TM.

      ASRT Credit Designation: 

      This activity has been approved by ASRT for 4.5 Category A continuing education credits.

      Deadline to Claim Credit

      Participants will have 90 days from the activity end date to complete the activity survey and claim continuing education credit.

      Schedule - All times eastern (NYC/USA)
      image


      Greg Yardley

      Sr. Medical Radiology Technologist and Researcher

      NASA Bone Mineral Laboratory

      Greg Yardley works as a SR. Medical Radiology Technologist and researcher in the NASA Bone Mineral Laboratory and NASA/JSC medical clinic for KBR in the government solutions division. His job requirements are performing and analyzing, Dual Energy x-ray absorptiometry (DXA) exams on both retired and active Astronauts. He also extracts, records, aids in bone density interpretation and distributes bone data from Dual Energy xray absorptiometry (DXA), Computed Tomography (CT), Magnetic resonance imaging devises. Greg also performs diagnostic medical x-rays for the NASA/JSC Flight medicine and occupational health clinic. 

      Greg began his healthcare career as an Emergency Medical Technician (EMT). He then furthered his medical education and received his certification as a registered radiology technologist. Upon completion of his Radiological Science courses. Greg has worked as a Radiology technologist in a Trauma level 1 Hospital, Level III hospital, urgent care, and multi-specialty clinic. At the time of his graduation Greg had also received extensive training not only in X-ray but also DXA, CT, and Ultrasound. In 2011 just previous to his current job Greg got a job as a Bone Density Technologist at a multi-specialty medical clinic where he performed and analyzed over 3000 DXA scans a year on every type of patient imaginable while also running the day-to-day operations of the Osteoporosis center.

      Michelle Swainson, PhD

      Lecturer in Physiology

      Lancaster Medical School, Lancaster University

      Michelle Swainson, PhD is a UK-based exercise physiologist with an honours degree in Sport and Exercise Science (Kinesiology), a master’s degree in Exercise Physiology, and a PhD focusing on fitness, body composition and cardiovascular disease risk in healthy adults. Michelle is a Lecturer in Physiology at Lancaster Medical School, Lancaster University, where her teaching includes clinical exercise physiology, public health challenges including obesity and ageing, exercise medicine, and optimising health outcomes through programme evaluation and interventions. She is the DXA lead for the new Health Innovation Imaging Suite, where her current research is focused on the assessment of visceral adipose tissue using DXA in both general and athletic populations, with specific interest on its use to predict cardiometabolic disease risk factors.  Michelle is a member of the ISCD Body Composition Education Committee, a British Association for the Sport and Exercise Sciences (BASES) Accredited Sport and Exercise Scientist, a committee member of the BASES Education and Teaching Special Interest Group, and the North West Network Representative for the UK Association for the Study of Obesity.

      image

      Statement of independence

      The ISCD maintains a policy on the use of commercial support, which ensures that all educational activities sponsored by the ISCD provide in-depth presentations that are fair, balanced, independent, and scientifically rigorous. ISCD requires faculty, planners, managers, and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by ISCD for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. Individual disclosures are included in the course material. No Commercial Support has been provided for this activity

      Disclaimer

      The information and suggestions presented at the courses, seminars and other programs sponsored by ISCD and other collaborating societies are subject to change and therefore should serve only as a foundation for further investigation and study. Any forms presented at our seminars or programs are samples only and are not necessarily authoritative. All information, procedures, and forms contained or used in such seminars or programs should serve only as a guide for use in specific situations.

      Disclosure of Unlabeled Use

      This educational activity may contain a discussion of published and/or investigational uses of agents that are not indicated by the FDA. ISCD does not recommend the use of any agent outside of the labeled indications. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for a discussion of approved indications, contraindications, and warnings.

      Privacy & Confidentiality Statement

      The ISCD will record the learner’s personal information as provided on evaluations to allow for the issuance and tracking of CME/CE certificates. The ISCD may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its educational program. No individual performance data or any other personal information collected for evaluations will be shared with third parties

      Attendance Cancellation Policy

      All changes in registration must be made in writing to education@iscd.org. Cancellations received 30 days prior to the start of the program are eligible for a full refund minus a $50 administrative fee. Cancellations received less than 30 days prior to the start of the course will not be refunded.

      Course Changes or Cancellations

      ISCD reserves the right to cancel the program, change dates, how the course is taught, and/or meeting location. If a program is canceled, all program fees will be refunded unless the registered participant elects to transfer to another program. Participants will be notified of any changes within 21 days of the course start date.

    3. Includes Multiple Live Events. The next is on 10/19/2024 at 10:00 AM (EDT)

      Course Date: October 19, 2024. The Pediatric Bone Densitometry Course provides the most current research and best-practice techniques for obtaining and interpreting bone mineral density (BMD) measurements in children and adolescents. This educational program is designed to improve learner competence in the area of pediatric densitometry. Learners will have the opportunity to take the knowledge gained from this educational program and properly/consistently apply it to their professional practices.

      Course Date

      October 19, 2024

      Course Description

      The Pediatric Bone Densitometry Course provides current research and best-practice techniques for the acquisition and interpretation of bone mineral density (BMD) in children and adolescents. This educational program is designed to improve learner competence in pediatric bone densitometry. By completing this course, attendees will gain conceptual and practical knowledge which can be applied in their professional practices.


      Target Audience

      The content is designed for healthcare providers with an interest in skeletal health assessment, including specialists, generalists and technologists working in family medicine, general and internal medicine, endocrinology, rheumatology, obstetrics/gynecology, radiology, pediatrics, physical and occupational therapy, nuclear medicine and research.


      Learning Objectives

      After attending the course, participants should be better prepared to:

      1. Recognize considerations and concerns with skeletal assessment in children and adolescents with a variety of medical conditions.

      2. Identify the most appropriate and reproducible sites for densitometry in children and adolescents.

      3. Evaluate technical aspects of bone assessment in children and adolescents.

      4. Describe the uses of measurement tools for acquiring bone densitometry assessments by DXA and other modalities.

      5. Summarize the elements to be included in a pediatric DXA report.


      Method of Participation

      This activity will be offered through Zoom, allowing the learner to watch and ask questions in a live format on October 19, 2024. At the end of the activity, learners will be asked to evaluate the activity online and then claim credit and print certificates. Participants will have 90 days from the activity end date to complete the activity survey and claim continuing education credit. 


      Rates

      image

      Cancellation Policy

      Attendee Cancellation Policy All changes in registration must be made in writing to education@iscd.org. Cancellations received 30 days prior to the start of the program are eligible for a full refund minus a $50 administrative fee. Cancellations received less than 30 days prior to the start of the course will not be refunded.

      Course Changes or Cancellations ISCD reserves the right to cancel the program, change dates and/or meeting location. If a program is canceled, all program fees will be refunded automatically unless the registered participant elects to transfer to another program. Participants will be notified of any changes within 21 days of the course start date.

      ACCME Joint Accreditation Statement:

      image

      In support of improving patient care, this activity has been planned and implemented by Amedco LLC and ISCD. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

      AMA PRA Category 1 Credit(s)™

      This activity is currently under review for accreditation targeting 3.75 AMA PRA Category 1 Credit(s)TM

      ASRT Credit Designation: 

      Successful completion of this activity qualifies for 4.5 Category A continuing education credits.

      Deadline to Claim Credit:

      Participants will have 90 days from the activity end date to complete the activity survey and claim continuing education credit.

      Schedule - October 19, 2024 - All times eastern (NYC/USA)

      image



      Kyla Kent, BA, CBDT

      Technical Director

      SAMBA Lab, Stanford University School of Medicine

      Kyla Kent, BA, CBDT, Technical Director of the SAMBA (Stanford Assessments of Muscle and Bone across the Ages) Lab, has been with Stanford University School of Medicine and the Palo Alto Veterans Affairs Health Care system since 1991 in the Stanford Prevention Research Center, the Musculo-Skeletal Research Lab and most recently the SAMBA Lab. Responsibilities include development and technical assessment of research protocols, clinical facility management, supervisor for clinical staff, performance of DXA, HRpQCT, Biodex and other measures related to research conducted in the areas of bone metabolism, structural assessment, body composition, exercise, sleep and healthy aging. Ms. Kent is a consultant in study design and instructor in bone density related imaging modalities for the Stanford Children’s Hospital, Palo Alto VA Hospital and Stanford Hospital/Stanford School of Medicine and internationally for bone mass measurement technique and analysis in growing skeletons. Currently acting in the position of Technical Director for the SAMBA Lab and as consultant developing a program for Quality DXA across all of Stanford’s clinical networks. Ms. Kent is an active member of the International Society for Clinical Densitometry (ISCD. She also has acted as the Director, clinical instructor and lecturer for a State certified training program for DXA.

      John J. Carey, MBBChBAO, MS, CCD, FRCPI

      Physician in Rheumatology, Osteology, and Medicine / Professor in Medicine

      Galway University Hospitals / University of Galway

      Prof. John J. Carey is a consultant physician in rheumatology and medicine, and clinical director of DXA, FLS programme and osteoporosis and metabolic bone disease at Galway University Hospitals, Ireland, and a Professor in Medicine at The National University of Ireland, Galway. He completed medical school in Ireland, and his post-graduate training in medicine, rheumatology and clinical research in the United States of America. He is a past-president of The International Society for Clinical Densitometry, current president of The Irish DXA Society and a member of The Committee for Scientific Affairs for the International Osteoporosis Foundation. He is faculty for the ISCD OE, Pediatric, VFR and Body Composition courses. His research interests focus on evidence synthesis and reality-based medicine, and optimizing the use of electronic health information, diagnostic testing and evidence in clinical practice.

      image

      Statement of Independence

      The ISCD maintains a policy on the use of commercial support, which ensures that all educational activities sponsored by the ISCD provide in-depth presentations that are fair, balanced, independent, and scientifically rigorous. ISCD requires faculty, planners, managers, and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by ISCD for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. Individual disclosures are included in the course material. No Commercial Support has been provided for this activity

      Disclaimer

      The information and suggestions presented at the courses, seminars and other programs sponsored by ISCD and other collaborating societies are subject to change and therefore should serve only as a foundation for further investigation and study. Any forms presented at our seminars or programs are samples only and are not necessarily authoritative. All information, procedures, and forms contained or used in such seminars or programs should serve only as a guide for use in specific situations.

      Disclosure of Unlabeled Use

      This educational activity may contain a discussion of published and/or investigational uses of agents that are not indicated by the FDA. ISCD does not recommend the use of any agent outside of the labeled indications. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for a discussion of approved indications, contraindications, and warnings.

      Privacy & Confidentiality Statement

      The ISCD will record the learner’s personal information as provided on evaluations to allow for the issuance and tracking of CME/CE certificates. The ISCD may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its educational program. No individual performance data or any other personal information collected for evaluations will be shared with third parties

      Attendance Cancellation Policy

      All changes in registration must be made in writing to education@iscd.org. Cancellations received 30 days prior to the start of the program are eligible for a full refund minus a $50 administrative fee. Cancellations received less than 30 days prior to the start of the course will not be refunded.

      Course Changes or Cancellations

      ISCD reserves the right to cancel the program, change dates, how the course is taught, and/or meeting location. If a program is canceled, all program fees will be refunded unless the registered participant elects to transfer to another program. Participants will be notified of any changes within 21 days of the course start date.

    4. Includes Multiple Live Events. The next is on 09/21/2024 at 10:00 AM (EDT)

      Course Date: September 21 & 22, 2024. The core elements of this program focus on performing quality DXA scans, dissecting the data and applying this knowledge to a technologist’s role in patient care. This course, which focuses on quality DXA, is innovative, interactive and informative. The course emphasizes technical excellence in the performance, analysis and troubleshooting of bone densitometry scans. It provides standard practices and applications to raise the quality of DXA scan procedures and their impact on patient care. The program is designed to enhance awareness of the technical expertise involved in performing bone densitometry and applying protocols to address the everyday challenges. Attendees with come away with a strong sense of the considerable impact that a technologist plays in the delivery of quality DXA, and how that influences patient management.

      Course Date

      September 21 & 22, 2024.


      Course Description

      The core elements of this program focus on performing quality DXA scans, dissecting the data and applying this knowledge to a technologist’s role in patient care. This course, which focuses on quality DXA, is innovative, interactive and informative.  The course emphasizes technical excellence in the performance, analysis and troubleshooting of bone densitometry scans. It provides standard practices and applications to raise the quality of DXA scan procedures and their impact on patient care. The program is designed to enhance awareness of the technical expertise involved in performing bone densitometry and applying protocols to address the everyday challenges. Attendees with come away with a strong sense of the considerable impact that a technologist plays in the delivery of quality DXA, and how that influences patient management.


      Target Audience

      The course is most appropriate for those involved in the performance of DXA scans and open to any health professional performing these scans.


      Learning Objectives

      After attending the course, participants should be better prepared to:

      1. Design and implement quality control and assurance practices.
      2. Perform a precision assessment and appreciate the requirement for clinical care.  
      3. Identify the anatomy relevant to clinical DXA scanning. 
      4. Implement consistent and appropriate technical acquisition and analysis techniques.  
      5. Perform a fracture risk assessment using FRAX. 
      6. Provide DXA interpreters sufficient information for a high-quality DXA report. 
      7. Discuss supplemental software and their application.
      8. Demonstrate how to access features within the DXA software. 
      9. Understand how specific medical conditions and medications affect bone density. 
      10. Critically evaluate DXA scans to identify acquisition and analysis errors and implement resolution methods.
      11. Recognize how technical errors impact clinical interpretation and patient care.



        Method of Participation

        This activity will be offered through zoom, allowing the learner to watch and ask questions in a live format on September 21 & 22, 2024. Learners will be asked to complete a post-course survey to indicate what they will change in their practice as a result of this activity.

        Registration Fee

        image



        Cancellation Policy

        Attendee Cancellation Policy All changes in registration must be made in writing to education@iscd.org. Cancellations received 30 days prior to the start of the program are eligible for a full refund minus a $50 administrative fee. Cancellations received less than 30 days prior to the start of the course will not be refunded.

        Course Changes or Cancellations ISCD reserves the right to cancel the program, change dates and/or meeting location. If a program is canceled, all program fees will be refunded automatically unless the registered participant elects to transfer to another program. Participants will be notified of any changes within 21 days of the course start date.

        ASRT Credit Designation 

        This activity has been approved by ASRT for 13.0 Category A continuing education credits.

        ASRT Credit Notice

        This course is a renewal. If you have taken the course since June 2022, you will not be able to claim ASRT again for this learning activity. If you have taken prior to June 2022, you can take this course again for credit.

        Deadline to Claim Credit

        Participants will have 90 days from the activity end date to complete the activity survey and claim continuing education credit.

        Schedule - Day 1 - All times Eastern (NYC/USA)

        image

        Schedule - Day 2 - All times Eastern (NYC/USA)

        image

        Anita Colquhoun, RTNM, MRT(N), CDT

        Charge Technologist

        Women's College Hospital

        Anita Colquhoun M.R.T.(N), CDT is the charge technologist in the Centre for Osteoporosis & Bone Health at the Women’s College Hospital in Toronto. Anita is a Nuclear Medical Technologist specialized in Bone Mineral Density (BMD). She has been working in the field of BMD since the early 1990s. Anita is an active member ISCD Technologist Faculty since 2000. She has served 2 terms on the Governing Board of the ISCD and is currently serving her third term as the Executive Secretary to the Board. As well as Chairing then Annual Meeting Committee from 2012-2016 Anita served and is still serving on several other committees within the ISCD. She has participated in a variety of research studies and has co-authored abstracts and papers. Anita has also co-written an on-line beginner BMD course as well as developed a competency profile and best practise in BMD for the Ontario Association of Medical Radiation Sciences.

        Lawrence Jankowski, CBDT

        Chief DXA Technologist/Research Coordinator

        Illinois Bone and Joint Institute, LLC

        Lawrence Jankowski is the chief DXA technologist and a research coordinator for Illinois Bone and Joint Institute, a multi-disciplinary 100+ physician practice with over 20 locations within Chicago and surrounding suburbs, specializing in orthopedic and rheumatologic health and sports performance and fitness. He started clinical imaging as a nuclear medicine technologist in 1978, performing both single- and dual- photon absorptiometry in beginning in 1987, and switched to DXA in 1990. He is also registered in radiology (limited), and is certified by the International Society for Clinical Densitometry (ISCD) first as a CDT in 1996, and then CBDT in 2001.

        In addition to his clinical and research duties, he is a technical instructor for the ISCD bone density courses, serves on the editorial board for the Journal of Clinical Densitometry, chairman of the Facility Accreditation Program, He has presented numerous posters on bone densitometry at scientific meetings, including the ASBMR, AAOS, NOF, as well as ISCD. Most recently, he served as task force chair for the 2019 Position Development Conference on cross-calibration and LSC determination in multiple scanner environments.

        Greg Yardley

        Sr. Medical Radiology Technologist and Researcher

        NASA Bone Mineral Laboratory

        Greg Yardley works as a SR. Medical Radiology Technologist and researcher in the NASA Bone Mineral Laboratory and NASA/JSC medical clinic for KBR in the government solutions division. His job requirements are performing and analyzing, Dual Energy x-ray absorptiometry (DXA) exams on both retired and active Astronauts. He also extracts, records, aids in bone density interpretation and distributes bone data from Dual Energy xray absorptiometry (DXA), Computed Tomography (CT), Magnetic resonance imaging devises. Greg also performs diagnostic medical x-rays for the NASA/JSC Flight medicine and occupational health clinic. 

        Greg began his healthcare career as an Emergency Medical Technician (EMT). He then furthered his medical education and received his certification as a registered radiology technologist. Upon completion of his Radiological Science courses. Greg has worked as a Radiology technologist in a Trauma level 1 Hospital, Level III hospital, urgent care, and multi-specialty clinic. At the time of his graduation Greg had also received extensive training not only in X-ray but also DXA, CT, and Ultrasound. In 2011 just previous to his current job Greg got a job as a Bone Density Technologist at a multi-specialty medical clinic where he performed and analyzed over 3000 DXA scans a year on every type of patient imaginable while also running the day-to-day operations of the Osteoporosis center.

        image

        Statement of Independence

        The ISCD maintains a policy on the use of commercial support, which ensures that all educational activities sponsored by the ISCD provide in-depth presentations that are fair, balanced, independent, and scientifically rigorous. ISCD requires faculty, planners, managers, and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by ISCD for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. Individual disclosures are included in the course material. No Commercial Support has been provided for this activity

        Disclaimer

        The information and suggestions presented at the courses, seminars and other programs sponsored by ISCD and other collaborating societies are subject to change and therefore should serve only as a foundation for further investigation and study. Any forms presented at our seminars or programs are samples only and are not necessarily authoritative. All information, procedures, and forms contained or used in such seminars or programs should serve only as a guide for use in specific situations.

        Disclosure of Unlabeled Use

        This educational activity may contain a discussion of published and/or investigational uses of agents that are not indicated by the FDA. ISCD does not recommend the use of any agent outside of the labeled indications. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for a discussion of approved indications, contraindications, and warnings.

        Privacy & Confidentiality Statement

        The ISCD will record the learner’s personal information as provided on evaluations to allow for the issuance and tracking of CME/CE certificates. The ISCD may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its educational program. No individual performance data or any other personal information collected for evaluations will be shared with third parties

        Attendance Cancellation Policy

        All changes in registration must be made in writing to education@iscd.org. Cancellations received 30 days prior to the start of the program are eligible for a full refund minus a $50 administrative fee. Cancellations received less than 30 days prior to the start of the course will not be refunded.

        Course Changes or Cancellations

        ISCD reserves the right to cancel the program, change dates, how the course is taught, and/or meeting location. If a program is canceled, all program fees will be refunded unless the registered participant elects to transfer to another program. Participants will be notified of any changes within 21 days of the course start date.

      1. Includes Multiple Live Events. The next is on 09/21/2024 at 10:00 AM (EDT)

        Course Date: September 21 & 22, 2024. The core elements of this course serve to educate healthcare providers about bone densitometry and osteoporosis and to apply standard practices to assure quality performance and interpretation of bone densitometry studies. The course is offered in two parts. The first day sets the standard to perform Quality DXA interpretation. Day 2 focuses on the clinical assessment, prevention, treatment and management of osteoporosis and the essential role that high-quality DXA plays in treatment initiation decisions and monitoring of osteoporotic patients. Individuals may register for either part of the course separately or as a combined program.

        Course Date

        September 21 & 22, 2024.


        Course Description

        The core elements of this course serve to educate healthcare providers about bone densitometry and osteoporosis and to apply standard practices to assure quality performance and interpretation of bone densitometry studies. The course is offered in two parts. The first day sets the standard to perform Quality DXA interpretation. Day 2 focuses on the clinical assessment, prevention, treatment and management of osteoporosis and the essential role that high-quality DXA plays in treatment initiation decisions and monitoring of osteoporotic patients. Individuals may register for either part of the course separately or as a combined program.


        Target Audience

        The course is most appropriate for those involved in the performance and interpretation of DXA scans and those managing patients with osteoporosis. It is open to MDs, PhDs, DOs, Nurse Practitioners, and Physician Assistants. Technologists may attend if they have previously taken the ISCD/IOF Osteoporosis Essentials for Technologists Course.


        Learning Objectives

        After attending the course, participants should be better prepared to:

        • Describe appropriate clinical evaluation of patients at risk for fragility fracture.
        • Summarize the value and importance of quality bone densitometry for the diagnosis of osteoporosis, assessment of fracture risk, and monitoring of BMD. 
        • Recognize errors in DXA analysis and reporting. 
        • Explain new and emerging guidelines that provide evidence-based information regarding skeletal health. 
        • Describe the use of current and new pharmacologic therapies for the management and treatment of osteoporosis, including adverse effects.

        Method of Participation

        This activity will be offered live streamed via Zoom, allowing the learner to watch and ask questions in a live format on September 21 & 22, 2024. Learners will be asked to complete a post-course survey to indicate what they will change in their practice as a result of this activity.

        Rates


        image


        Cancellation Policy

        Attendee Cancellation Policy All changes in registration must be made in writing to education@iscd.org. Cancellations received 30 days prior to the start of the program are eligible for a full refund minus a $50 administrative fee. Cancellations received less than 30 days prior to the start of the course will not be refunded.

        Course Changes or Cancellations ISCD reserves the right to cancel the program, change dates and/or meeting location. If a program is canceled, all program fees will be refunded automatically unless the registered participant elects to transfer to another program. Participants will be notified of any changes within 21 days of the course start date.

        ACCME Joint Accreditation Statement

        In support of improving patient care, this activity has been planned and implemented by Amedco LLC and ISCD. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

        image

        AMA PRA Category 1 Credit(s)™

        Amedco LLC designates this live activity for a maximum of 13.00 AMA PRA Category 1 CreditsTM

        Physicians should claim only the credit commensurate with the extent of their participation in the activity.

        Deadline to Claim Credit

        Participants will have 90 days from the activity end date to complete the activity survey and claim continuing education credit.

         Schedule - September 21st, 2024 - All times Eastern Standard Time (NYC/USA)

        image


         Schedule - September 22nd, 2024 - All times Eastern Standard Time (NYC/USA)

        image


        Dr. Sanford Baim, MD, FACR, CCD

        Professor of Medicine, Director of Bone Metabolic Disease, Division of Endocrinology and Metabolism

        RUSH University Medical Center

        Dr. Sanford Baim is Professor of Medicine, Director of Bone Metabolic Disease, Division of Endocrinology and Metabolism at RUSH University Medical Center. He is past president of the International Society for Clinical Densitometry, has published numerous articles, participated in the development of an interactive web-based teaching tool for bone densitometry and is presently engaged in osteoporosis clinical outcomes research. Additionally, he has served on the leadership boards of numerous conferences and steering committees tasked with setting official positions on the diagnoses and treatment of metabolic bone diseases, such as osteoporosis. Dr. Baim is currently developing a comprehensive, multidisciplinary, integrative strategic plan for the prevention of osteoporosis throughout the Rush University medical system.

        E. Michael Lewiecki, MD, FACP, FACE, CCD

        Director

        New Mexico Clinical Research & Osteoporosis Center, Inc.

        E. Michael Lewiecki, MD, CCD, FACP, FACE, FASBMR, is Director of New Mexico Clinical Research & Osteoporosis Center and Director of Bone Health TeleECHO at University of New Mexico Health Sciences Center in Albuquerque, NM. His is a consultant in osteoporosis and metabolic bone disease, supervisor and interpreter of bone density studies, and an educator with a special interest in the evaluation and treatment of osteoporosis and metabolic bone diseases. He has been principal investigator for many osteoporosis clinical trials and is author of over 300 publications in peer-reviewed medical journals, as well as books, book chapters, and online publications on osteoporosis. Dr. Lewiecki is past-president of the International Society for Clinical Densitometry (ISCD) and current president of the Osteoporosis Foundation of New Mexico (OFNM). He is an editor for Osteoporosis International, and is on the editorial boards of the Journal of Bone and Mineral Research and the Journal of Clinical Densitometry. He has received national and international awards that include the 2021 “Dr. John P. Bilezikian ISCD Global Leadership Award” and the 2021 “Lawrence G. Raisz Memorial Lecture Award” with the Bone Health & Osteoporosis Foundation. Dr. Lewiecki is the program director of the annual Santa Fe Bone Symposium, the flagship activity of the OFNM.

        Christopher Shuhart, MD, MHA, CCD

        Director of the Bone Health and Osteoporosis Center

        Swedish Medical Group

        Dr. Shuhart is the founder and Director of the Bone Health and Osteoporosis Center at Swedish Medical Group in Seattle, Washington. He is Past-President of the International Society for Clinical Densitometry (ISCD) from 2019-2020, with multiple years in Executive and Board of Directors roles, and has served on numerous ISCD committees and task forces. He received ISCD's Paul Miller Service Award in 2022.

        He is a co-author on the ISCD’s 2016 publication of “Best Practices” in the Journal of Clinical Densitometry, and was the Organizing Chair for the 2019 ISCD Position Development Conference (PDC) in Kuala Lumpur, Malaysia, as well as lead author of the 2019 PDC Executive Summary. He is the Administrative Chair for the 2023 PDC.

        Dr. Shuhart received his medical degree from Dartmouth Medical School in 1987, and his Masters in Health Administration from the University of Washington in 2009. He is board certified in Family Medicine since 1990.

        image

        Statement of Independence

        The ISCD maintains a policy on the use of commercial support, which ensures that all educational activities sponsored by the ISCD provide in-depth presentations that are fair, balanced, independent, and scientifically rigorous. ISCD requires faculty, planners, managers, and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by ISCD for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. Individual disclosures are included in the course material. No Commercial Support has been provided for this activity

        Disclaimer

        The information and suggestions presented at the courses, seminars and other programs sponsored by ISCD and other collaborating societies are subject to change and therefore should serve only as a foundation for further investigation and study. Any forms presented at our seminars or programs are samples only and are not necessarily authoritative. All information, procedures, and forms contained or used in such seminars or programs should serve only as a guide for use in specific situations.

        Disclosure of Unlabeled Use

        This educational activity may contain a discussion of published and/or investigational uses of agents that are not indicated by the FDA. ISCD does not recommend the use of any agent outside of the labeled indications. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for a discussion of approved indications, contraindications, and warnings.

        Privacy & Confidentiality Statement

        The ISCD will record the learner’s personal information as provided on evaluations to allow for the issuance and tracking of CME/CE certificates. The ISCD may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its educational program. No individual performance data or any other personal information collected for evaluations will be shared with third parties

        Attendance Cancellation Policy

        All changes in registration must be made in writing to education@iscd.org. Cancellations received 30 days prior to the start of the program are eligible for a full refund minus a $50 administrative fee. Cancellations received less than 30 days prior to the start of the course will not be refunded.

        Course Changes or Cancellations

        ISCD reserves the right to cancel the program, change dates, how the course is taught, and/or meeting location. If a program is canceled, all program fees will be refunded unless the registered participant elects to transfer to another program. Participants will be notified of any changes within 21 days of the course start date.

      2. This activity was designed to allow learners to understand when vitamin D is helpful in optimizing bone health, which preparations are the best to use, and which dosing regimen is most advantageous. Attendees can listen to a clear lecture by one of the leaders in the field of vitamin D and understand the state of the art of how and when to dose vitamin D most effectively.

        Activity approved for 1.00 ASRT Category A Credits
        Activity approved for up to 1.0 AMA PRA Category 1 Credits™ 
        Activity Expires October 1, 2024

        Activity Description

        This activity was designed to allow learners to understand when vitamin D is helpful in optimizing bone health, which preparations are the best to use, and which dosing regimen is most advantageous. Attendees can listen to a clear lecture by one of the leaders in the field of vitamin D and understand the state of the art of how and when to dose vitamin D most effectively.

        Learning Objectives:

        1. Identify under which circumstances vitamin D is helpful
        2. Understand which vitamin D preparation is most useful
        3. Understand which vitamin D treatment regimen and schedule is most helpful

        Instructions:

        Clinicians and Technologists are required to answer a set of online test questions following the review of the video and will have up to three attempts to answer questions correctly before losing credit for the activity. Once the activity test has been passed (75% or higher), you will be asked to evaluate the activity online and then be allowed to claim credit and print certificates.

        Registration Fees

        image

        Cancellation Policy

        On-Demand/ Enduring Material Cancellation Purchases of on-demand or enduring educational materials are non-refundable. 

        On-Demand/Enduring Material Program Changes or Cancellations  ISCD reserves the right to cancel the program and change the dates of the offering. All program fees will be refunded if a program is canceled unless the registered participant elects to transfer to another program.

        ACCME Accreditation Statement

        The International Society for Clinical Densitometry is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to offer continuing medical education for physicians. This activity is provided by the International Society for Clinical Densitometry. For information about the accreditation of this program, please contact ISCD at +1.860.259.1000 or inquire at education@iscd.org.

        AMA PRA Category 1 Credit(s)™

        The International Society for Clinical Densitometry designates this enduring educational activity for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should only claim credits commensurate with the extent of their participation in the activity.

        ASRT Credit Designation 

        This activity has been approved by ASRT for 1.00 Category A continuing education credits.

        Date of Original Release and most recent Review or Update 

        This activity was most recently reviewed and released on September 1, 2023, and will expire on October 1, 2024.

        Dr Neil Binkley MD, CCD

        Professor

        University of Wisconsin Madison

        Dr. Neil Binkley earned his medical degree from the University of Wisconsin and subsequently trained in Internal Medicine at the Marshfield Clinic. After several years in private practice, he returned to the University of Wisconsin and completed a Geriatrics fellowship. He is a Professor in the Divisions of Geriatrics and Endocrinology at the University of Wisconsin School of Medicine and Public Health. He is also Director of the UW Osteoporosis Clinical Research Program and Associate Director of the UW Institute on Aging. He is past President of the International Society for Clinical Densitometry, Associate Editor of Osteoporosis International and a member of the International Osteoporosis Foundation Committee of Scientific Advisors. His current research involves improvement in 25(OH)D measurement, evaluation of approaches to optimize assessment of vitamin D status, evaluation of functional assessment in older adults and the importance of sarcopenia in fracture risk. Dr. Binkley has published over 300 papers, served on expert committees and panels for AACE, ASBMR, IOF and ISCD.

        Course Planners and Managers

        Fiore Barbini - No Financial Relationships to Disclose

        Jill Seely, BS, CAHI, CMA - No Financial Relationships to Disclose

        Harold Rosen, MD, CCD -  No Financial Relationships to Disclose

        Course Content Reviewers

        Wendy Tolman-Andrews -  No Financial Relationships to Disclose

        Content Authors

        Dr Neil Binkley, MD, CCD - Disclosure(s): Amgen: Consulting Fee, Contracted Research; Radius: Contracted Research

        image

        Statement of Independence

        The ISCD maintains a policy on the use of commercial support, which ensures that all educational activities sponsored by the ISCD provide in-depth presentations that are fair, balanced, independent, and scientifically rigorous. ISCD requires faculty, planners, managers, and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by ISCD for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. Individual disclosures are included in the course material. No Commercial Support has been provided for this activity

        Disclaimer

        The information and suggestions presented at the courses, seminars and other programs sponsored by ISCD and other collaborating societies are subject to change and therefore should serve only as a foundation for further investigation and study. Any forms presented at our seminars or programs are samples only and are not necessarily authoritative. All information, procedures, and forms contained or used in such seminars or programs should serve only as a guide for use in specific situations.

        Disclosure of Unlabeled Use 

        This educational activity may contain a discussion of published and/or investigational uses of agents that are not indicated by the FDA. ISCD does not recommend the use of any agent outside of the labeled indications. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

        Privacy & Confidentiality Statement

        The ISCD will record the learner’s personal information as provided on evaluations to allow for the issuance and tracking of CME/CE certificates. The ISCD may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its educational program. No individual performance data or any other personal information collected for evaluations will be shared with third parties

        Attendee Cancellation Policy

        All changes in registration must be made in writing to education@iscd.org. Purchase of on-demand or enduring educational materials are non-refundable.

        Course Changes or Cancellations

        ISCD reserves the right to cancel the program and change the dates of the offering. All program fees will be refunded if a program is canceled unless the registered participant elects to transfer to another program.

      3. This activity will give an update on diagnosis and indications for surgery with a focus on bone. This activity was designed to allow learners to understand how to approach which patients to refer for surgery for hyperparathyroidism.

        Activity approved for 1.0 ASRT Category A Credits
        Activity approved for up to 1.0 AMA PRA Category 1 Credits™
        Activity Expires August 1, 2024

        Activity Description

        This activity will give an update on diagnosis and indications for surgery with a focus on bone. This activity was designed to allow learners to understand how to approach which patients to refer for surgery for hyperparathyroidism.

        Learning Objectives

        1. The attendee will understand the current guidelines for when to refer patients with hyperparathyroidism for surgery.

        2. The attendee will understand that in patients with eGFR<60, hyperparathyroidism is a more aggressive disease and warrants surgery.

        3. The attendee will understand that there is no clear benefit to quality of life parameters associated with parathyroidectomy.

        Instructions

        Clinicians and Technologists are required to answer a set of online test questions following the review of the video and will have up to three attempts to answer questions correctly before losing credit for the activity. Once the activity test has been passed (75% or higher), you will be asked to evaluate the activity online and then be allowed to claim credit and print certificates.

        Registration Fees

        image

        Cancellation Policy

        On-Demand/ Enduring Material Cancellation Purchases of on-demand or enduring educational materials are non-refundable. 

        On-Demand/Enduring Material Program Changes or Cancellations  ISCD reserves the right to cancel the program and/or change dates of offering. All program fees will be refunded if a program is canceled unless the registered participant elects to transfer to another program.

        ACCME Accreditation Statement

        The International Society for Clinical Densitometry is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to offer continuing medical education for physicians. This activity is provided by the International Society for Clinical Densitometry. For information about the accreditation of this program, please contact ISCD at +1.860.259.1000 or inquire at education@iscd.org.

        AMA PRA Category 1 Credit(s)™

        The International Society for Clinical Densitometry designates this enduring educational activity for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should only claim credits commensurate with the extent of their participation in the activity.

        ASRT Credit Designation 

        This activity has been approved by ASRT for 1.00 Category A continuing education credits.

        Date of Original Release and most recent Review or Update 

        This activity was most recently reviewed and released on May 22, 2023, and will expire on August 1, 2024.

        John P. Bilezikian, MD, PhD

        Professor of Medicine, Vice Chair

        Columbia University, Vagelos College of Physicians & Surgeons, Department of Medicine for International Education and Research

        Dr. Bilezikian, the Dorothy L. and Daniel H. Silberberg Professor of Medicine at the Vagelos College of Physicians & Surgeons, Columbia University, is Vice Chair of the Department of Medicine for International Education and Research and Chief, Emeritus, of the Division of Endocrinology. He is Director, Emeritus, of the Metabolic Bone Diseases Program at Columbia University Medical Center. Dr. Bilezikian received his undergraduate training at Harvard College and his medical training at the College of Physicians & Surgeons.  He completed four years of house staff training (internship, residency, and Chief Residency) on the Medical Service at Columbia Presbyterian Medical Center.  Dr. Bilezikian received his training in Metabolic Bone Diseases and in Endocrinology at the National Institutes of Health in the Mineral Metabolism Branch under the tutelage of Dr. Gerald Aurbach.  He belongs to a number of professional societies including the American Society of Bone and Mineral Research, of which he served as President (ASBMR), 1995-1996 and the International Society of Clinical Densitometry (ISCD), of which he served as President, 1999-2001. He is a member of the Endocrine Society, the American Federation for Clinical Research, the American Society for Clinical Investigation, the Association of American Physicians, the American Association of Clinical Endocrinologists, the American Society for Pharmacology and Experimental Therapeutics, and the American College of Endocrinology that has designated him Master. He served on the Board of Governors of the International Osteoporosis Foundation (1999-2015) and is a current member of its Committee of Scientific Advisors. He is Chair of the Endocrine Fellows Foundation. He served as Editor-in-Chief of the Journal of Clinical Endocrinology and Metabolism and as Senior Associate Editor of the Journal of Bone and Mineral Research. He is Executive Advisory Editor of Bone Research. His books include Editor-in-Chief of The Parathyroids (1994, 2001, 2015), and co-editor of The Aging Skeleton (1999), Dynamics of Bone and Cartilage Metabolism (1999, 2006), Principles of Bone Biology (1996, 2002, 2008, 2020) and Osteoporosis in Men (2010). He is Editor-in-Chief of the 9th and 10th Editions of the Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism (2019, 2023). He has been on numerous panels, including serving as Chair of the NIH Consensus Development Panel on Optimal Calcium Intake (1994), Co-chair of the last four International Workshops on Primary Hyperparathyroidism (2002, 2008, 2013, 2022) and of the International Workshops on Hypoparathyroidism (2015, 2022) and Controversies in Vitamin D (2017-).  Dr. Bilezikian's major research interests are related to the clinical investigation of metabolic bone diseases, particularly primary hyperparathyroidism, hypoparathyroidism and osteoporosis, His studies of parathyroid hormone in these disorders regarding etiology, clinical manifestations, pathophysiology, mechanisms of skeletal involvement, and therapy are known throughout the world as landmark contributions to our knowledge of these disorders. He has been continuously funded by the NIH since 1974. Over 925 publications speak to these active original investigative initiatives as well as his authorship of many reference sources of endocrinology and metabolic bone diseases.

        Dr. Bilezikian is the recipient of the Distinguished Physician Award of the Endocrine Society, the Frederic C. Bartter Award of the ASBMR for Excellence in Clinical Research, and the First Annual Global Leadership Award of the ISCD.  In 2009, he received the Gideon A. Rodan Excellence in Mentorship Award from the ASBMR. He received the Laureate Distinguished Educator Award of the Endocrine Society in 2014. In 2014, he was made honorary member of the Brazilian Society of Endocrinology and Metabolism and the Association of Brazilian Orthopedic Osteologists. In 2015, he received the Oscar Gluck Humanitarian Award of the ISCD and the Inaugural Global Educator of the Year Award from McMaster University in Canada.  In 2017, he was named Honorary Member of the Russian Osteoporosis Association. Dr. Bilezikian has received Lifetime Achievement and Recognition Awards of the California and Boston Armenian American Medical Societies and the Armenian American Health Professionals Organization. In 2017, he received the Doctor Honoris Causa Award from the Carol Davila School of Medicine in Bucharest, Romania and from the University of Pisa, in Pisa, Italy. He received the Distinguished Physician Award of the American Association of Clinical Endocrinologists in 2018. He received the Ellis Island Congressional Medal of Honor from the United States Government in 2018. Also, in 2018 he received a Parliamentary Medal of Honor from the Government of Armenia for distinguished service and a similar honor from the Government of Brazil. In 2019, he received the Gold Medal for Outstanding Achievements in Medical Research, the highest honor that Columbia University’s College of Physicians and Surgeons bestows on its graduates. In 2020, Dr. Bilezikian received the ASBMR William F. Neuman Award for highest scientific achievement. In 2023, he received a Special Recognition Award from the 6th International Medical Congress of Armenia.

         

        Course Planners and Managers

        Harold Rosen, MD, CCD No Financial Relationships to Disclose
        Jill Seely, BS, CMA, CAHI No Financial Relationships to Disclose
        Fiore Barbini No Financial Relationships to Disclose

        Course Content Reviewers

        Wendy Tolman-Andrews, CBDT No Financial Relationships to Disclose

        Course Faculty, Moderators, and Content Authors

        John Bilezikian, MD, PhD  - Disclosures: Amgen, Abiogen, Ascendis, NovoNordisk, Takeda Pharmaceuticals, Radius, Ultragenyx: Advisory Boards and Consultant Fees; Regeneron; Data and Safety Monitoring Board

        image

        Statement of Independence

        The ISCD maintains a policy on the use of commercial support, which ensures that all educational activities sponsored by the ISCD provide in-depth presentations that are fair, balanced, independent, and scientifically rigorous. ISCD requires faculty, planners, managers, and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by ISCD for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. Individual disclosures are included in the course material. No Commercial Support has been provided for this activity

        Disclaimer

        The information and suggestions presented at the courses, seminars and other programs sponsored by ISCD and other collaborating societies are subject to change and therefore should serve only as a foundation for further investigation and study. Any forms presented at our seminars or programs are samples only and are not necessarily authoritative. All information, procedures, and forms contained or used in such seminars or programs should serve only as a guide for use in specific situations.

        Disclosure of Unlabeled Use 

        This educational activity may contain a discussion of published and/or investigational uses of agents that are not indicated by the FDA. ISCD does not recommend the use of any agent outside of the labeled indications. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

        Privacy & Confidentiality Statement

        The ISCD will record the learner’s personal information as provided on evaluations to allow for the issuance and tracking of CME/CE certificates. The ISCD may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its educational program. No individual performance data or any other personal information collected for evaluations will be shared with third parties

        Attendee Cancellation Policy

        All changes in registration must be made in writing to education@iscd.org. Purchase of on-demand or enduring educational materials are non-refundable.

        Course Changes or Cancellations

        ISCD reserves the right to cancel the program and/or change dates of offering. All program fees will be refunded if a program is canceled unless the registered participant elects to transfer to another program. 

      4. This activity was designed to help learners understand how to diagnose and manage rare bone diseases such as hypophosphatemic rickets, hypophosphatasia and osteogenesis imperfecta.

        Activity approved for 1.00 ASRT Category A Credits
        Activity approved for up to 1.0 AMA PRA Category 1 Credits™ 
        Activity Expires October 1, 2024

        Activity Description

        This activity was designed to help learners understand how to diagnose and manage rare bone diseases such as hypophosphatemic rickets, hypophosphatasia and osteogenesis imperfecta.

        Learning Objectives:

        1. The attendee will understand how to diagnose and manage hypophosphatemic rickets
        2. The attendee will understand how to diagnose and manage hypophosphatasia
        3. The attendee will understand how to diagnose and manage osteogenesis imperfecta

        Instructions:

        Clinicians and Technologists are required to answer a set of online test questions following the review of the video and will have up to three attempts to answer questions correctly before losing credit for the activity. Once the activity test has been passed (75% or higher), you will be asked to evaluate the activity online and then be allowed to claim credit and print certificates.

        Registration Fees

        image

        Cancellation Policy

        On-Demand/ Enduring Material Cancellation Purchases of on-demand or enduring educational materials are non-refundable. 

        On-Demand/Enduring Material Program Changes or Cancellations  ISCD reserves the right to cancel the program and change the dates of the offering. All program fees will be refunded if a program is canceled unless the registered participant elects to transfer to another program.

        ACCME Accreditation Statement

        The International Society for Clinical Densitometry is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to offer continuing medical education for physicians. This activity is provided by the International Society for Clinical Densitometry. For information about the accreditation of this program, please contact ISCD at +1.860.259.1000 or inquire at education@iscd.org.

        AMA PRA Category 1 Credit(s)™

        The International Society for Clinical Densitometry designates this enduring educational activity for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should only claim credits commensurate with the extent of their participation in the activity.

        ASRT Credit Designation 

        This activity has been approved by ASRT for 1.00 Category A continuing education credits.

        Date of Original Release and most recent Review or Update 

        This activity was most recently reviewed and released on September 1, 2023, and will expire on October 1, 2024.

        Manju Chandran, MD, FACP, FACE, FAMS

        Senior Consultant and Director

        Singapore General Hospital

        Dr Manju Chandran is a Senior Consultant Endocrinologist and Director of the Osteoporosis and Bone Metabolism Unit at Singapore General Hospital (SGH).

        She is the Chairperson of the Asia Pacific Consortium on Osteoporosis (APCO), past Chairperson of the Chapter of Endocrinologists, College of Physicians, Academy of Medicine, Singapore; elected Member of the Council of Scientific Advisors and Board Member of the IOF and Deputy Chair of its Asia Pacific Regional Advisory Council; Past President of the Endocrine and Metabolic Society of Singapore, Vice Chair of the Asia Pacific Panel of the ISCD, and Treasurer of the Osteoporosis Society of Singapore. She was a Member of the Publications Committee of the ASBMR and current member of its Women In Bone and Mineral Research Committee. She has won a multitude of international awards, including the most prestigious of the IOF awards- the 2021 Olof Johnell Science Award, the IOF Committee of National Societies Medal 2015; the IOF International Young Investigator Award 2013, the SGH Most Inspiring Mentor Award 2021 and the Singhealth DUKE NUS Most Caffeinated Researcher Award 2020. OPTIMAL- the Secondary Fracture Prevention and Fracture Liaison Service she set up at SGH was the 3rd in the world and the 1st in the Asia Pacific to win the Gold Star in the IOF’s Capture the Fracture Global Map of Best Practice in 2015.

        Her research and clinical interests include the epidemiology and health economic burden of osteoporosis, rare bone disorders, diabetes and bone health and parathyroid disorders. She has close to160 publications more than ¾ of which she is the first or senior author of. She is the Section Co-Editor on Osteoporosis in the ASBMR's Primer on Metabolic Bone Diseases. She is a regular Keynote, Plenary and Symposium speaker at regional and international conferences in the fields of Endocrinology and Bone Metabolism.

        Disclosure(s): No financial relationships to disclose

        Course Planners and Managers

        Fiore Barbini - No Financial Relationships to Disclose

        Jill Seely, BS, CAHI, CMA - No Financial Relationships to Disclose

        Harold Rosen, MD, CCD -  No Financial Relationships to Disclose

        Course Content Reviewers

        Wendy Tolman-Andrews -  No Financial Relationships to Disclose

        Content Authors

        Manju Chandran, MD, FACP, FACE, FAMS- No Financial Relationships to Disclose

        image

        Statement of Independence

        The ISCD maintains a policy on the use of commercial support, which ensures that all educational activities sponsored by the ISCD provide in-depth presentations that are fair, balanced, independent, and scientifically rigorous. ISCD requires faculty, planners, managers, and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by ISCD for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. Individual disclosures are included in the course material. No Commercial Support has been provided for this activity

        Disclaimer

        The information and suggestions presented at the courses, seminars and other programs sponsored by ISCD and other collaborating societies are subject to change and therefore should serve only as a foundation for further investigation and study. Any forms presented at our seminars or programs are samples only and are not necessarily authoritative. All information, procedures, and forms contained or used in such seminars or programs should serve only as a guide for use in specific situations.

        Disclosure of Unlabeled Use 

        This educational activity may contain a discussion of published and/or investigational uses of agents that are not indicated by the FDA. ISCD does not recommend the use of any agent outside of the labeled indications. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

        Privacy & Confidentiality Statement

        The ISCD will record the learner’s personal information as provided on evaluations to allow for the issuance and tracking of CME/CE certificates. The ISCD may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its educational program. No individual performance data or any other personal information collected for evaluations will be shared with third parties

        Attendee Cancellation Policy

        All changes in registration must be made in writing to education@iscd.org. Purchase of on-demand or enduring educational materials are non-refundable.

        Course Changes or Cancellations

        ISCD reserves the right to cancel the program and change the dates of the offering. All program fees will be refunded if a program is canceled unless the registered participant elects to transfer to another program.

      5. This activity was designed to allow learners to understand the relationship between radius BMD and overall fracture risk as well as the impact of wrist fractures on skeletal health. Attendees can listen to a cogent, clear, concise and well-referenced lecture after which they will understand how the role of wrist BMD in assessing skeletal fragility and predicting risk of future fractures, and its role in osteoporosis treatment decisions.

        Activity approved for 1.00 ASRT Category A Credits
        Activity approved for up to 1.0 AMA PRA Category 1 Credits™ 
        Activity Expires September 1, 2024

        Activity Description

        This activity was designed to allow learners to understand the relationship between radius BMD and overall fracture risk as well as the impact of wrist fractures on skeletal health. Attendees can listen to a cogent, clear, concise and well-referenced lecture after which they will understand how the role of wrist BMD in assessing skeletal fragility and predicting risk of future fractures, and its role in osteoporosis treatment decisions.

        Learning Objectives:

        1. Identify the relationship between radius BMD and overall fracture risk.
        2. Discuss the impact of wrist fractures on skeletal health.
        3. Describe the role of routine radius BMD in the screening algorithms for osteoporosis.

        Instructions:

        Clinicians and Technologists are required to answer a set of online test questions following the review of the video and will have up to three attempts to answer questions correctly before losing credit for the activity. Once the activity test has been passed (75% or higher), you will be asked to evaluate the activity online and then be allowed to claim credit and print certificates.

        Registration Fees

        image

        Cancellation Policy

        On-Demand/ Enduring Material Cancellation Purchases of on-demand or enduring educational materials are non-refundable. 

        On-Demand/Enduring Material Program Changes or Cancellations  ISCD reserves the right to cancel the program and change the dates of the offering. All program fees will be refunded if a program is canceled unless the registered participant elects to transfer to another program.

        ACCME Accreditation Statement

        The International Society for Clinical Densitometry is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to offer continuing medical education for physicians. This activity is provided by the International Society for Clinical Densitometry. For information about the accreditation of this program, please contact ISCD at +1.860.259.1000 or inquire at education@iscd.org.

        AMA PRA Category 1 Credit(s)™

        The International Society for Clinical Densitometry designates this enduring educational activity for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should only claim credits commensurate with the extent of their participation in the activity.

        ASRT Credit Designation 

        This activity has been approved by ASRT for 1.00 Category A continuing education credits.

        Date of Original Release and most recent Review or Update 

        This activity was most recently reviewed and released on August 1, 2023, and will expire on September 1, 2024.

        Jane A. Cauley, DrPH

        Chair and Distinguished Professor

        University of Pittsburgh, School of Public Health, Dept of Epidemiology

        Dr. Cauley is Distinguished Professor and Interim Chair, Dept of Epidemiology, University of Pittsburgh. Dr. Cauley has been involved in osteoporosis research for over 30 yrs and is the Past-President of the American Society for Bone and Mineral Research (ASBMR). Dr. Cauley is the PI of the Osteoporotic Fractures in Men Study at the University of Pittsburgh, since its inception. She is Dual PI of a funded RO1 entitled, Bone microarchitecture and bone strength: relationships to muscle quantity, quality and function in older adults.

        Dr. Cauley also served on several large, multi-site longitudinal studies and clinical trials focusing on issues related to aging and osteoporosis, including as PI of the Study of Osteoporotic Fractures (SOF) (10,366 women age 65+) at the Pittsburgh field site, 1986-2016. SOF evolved from a study focused on osteoporosis to an important study of aging. She was also Co-PI of the Health Aging and Body Composition Study, one of the first studies to quantify intermuscular fat and relate this to disability, fractures and mortality. She served as the clinical site PI of several major randomized clinical trials of treatments for osteoporosis including the Fracture Intervention Trial (FIT) (alendronate) and its extension, FLEX ( FIT Long-term extension study); the Health Outcomes related to Zolendronic acid-Pivotal Fracture Study( HORIZON-PFS); Multiple Outcomes of Raloxifene Evaluation (MORE); the NIA sponsored Testosterone trials and was Co-PI of the Women’s Health Initiative, serving as the Chair or Co-Chair of the Calcium Vitamin D committee for the duration of the trial. She was Chair of the recruitment committee for both the Testosterone Trials and NIA sponsored ENRGIZE trial testing whether fish oil or Losartan reduced inflammation and improved mobility. Currently, she is Co-Chair of an ASBMR Task Force examining the use of race and ethnicity in clinical algorithms related to fracture risk.

        Disclosure(s): No financial relationships to disclose

        Course Planners and Managers

        Fiore Barbini - No Financial Relationships to Disclose

        Jill Seely, BS, CAHI, CMA - No Financial Relationships to Disclose

        Wendy Tolman-Andrews -  No Financial Relationships to Disclose

        Course Content Reviewers

        Harold Rosen, MD, CCD-  No Financial Relationships to Disclose

        Content Authors

        Jane A. Cauley, DrPH - No Financial Relationships to Disclose

        image

        Statement of Independence

        The ISCD maintains a policy on the use of commercial support, which ensures that all educational activities sponsored by the ISCD provide in-depth presentations that are fair, balanced, independent, and scientifically rigorous. ISCD requires faculty, planners, managers, and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by ISCD for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. Individual disclosures are included in the course material. No Commercial Support has been provided for this activity

        Disclaimer

        The information and suggestions presented at the courses, seminars and other programs sponsored by ISCD and other collaborating societies are subject to change and therefore should serve only as a foundation for further investigation and study. Any forms presented at our seminars or programs are samples only and are not necessarily authoritative. All information, procedures, and forms contained or used in such seminars or programs should serve only as a guide for use in specific situations.

        Disclosure of Unlabeled Use 

        This educational activity may contain a discussion of published and/or investigational uses of agents that are not indicated by the FDA. ISCD does not recommend the use of any agent outside of the labeled indications. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

        Privacy & Confidentiality Statement

        The ISCD will record the learner’s personal information as provided on evaluations to allow for the issuance and tracking of CME/CE certificates. The ISCD may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its educational program. No individual performance data or any other personal information collected for evaluations will be shared with third parties

        Attendee Cancellation Policy

        All changes in registration must be made in writing to education@iscd.org. Purchase of on-demand or enduring educational materials are non-refundable.

        Course Changes or Cancellations

        ISCD reserves the right to cancel the program and change the dates of the offering. All program fees will be refunded if a program is canceled unless the registered participant elects to transfer to another program.